Shree Ganesh Remedies Board of Directors
Get the latest insights into the leadership at Shree Ganesh Remedies. Learn about the experienced professionals guiding the company's strategy and governance.
| Name | Position |
|---|---|
| Mr. Chandulal Manubhai Kothia | Chairman & Managing Director |
| Mr. Parth Chandulal Kothia | Whole Time Director |
| Mr. Gunjan Chandulal Kothia | Whole Time Director |
| Mr. Priyam Surendra Shah | Independent Director |
| Mr. Maulikkumar Jaysukhbhai Sudani | Independent Director |
| Mr. Parulben Sahani | Independent Director |
Shree Ganesh Remedies Share price
SGRL
590
3.40 (-0.57%)Last updated on 4 Sep, 2025 | 15:28 IST
BUYSELL
Today's High
609.00
Today's Low
585.20
52 Week Low
500.00
52 Week High
950.00
The current prices are delayed, login to your account for live prices
LoginShree Ganesh Remedies FAQs
The board at Shree Ganesh Remedies consists of experienced professionals, including Mr. Chandulal Manubhai Kothia , Mr. Parth Chandulal Kothia , and others, overseeing the company’s strategic and corporate governance.
Directors at Shree Ganesh Remedies are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.
As of the latest update, Mr. Chandulal Manubhai Kothia is the current chairman at Shree Ganesh Remedies.
Executive directors at Shree Ganesh Remedies are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.
Yes, Shree Ganesh Remedies adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.
At Shree Ganesh Remedies, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.